Global and Region Dermatophytosis Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Ringworm on the skin like athlete's foot (tinea pedis) and jock itch (tinea cruris) can usually be treated with non-prescription antifungal creams, lotions, or powders applied to the skin for 2 to 4 weeks.

    The report details the trend, potential and market size of Dermatophytosis Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Dermatophytosis Therapeuticsmarket, defines the market attractiveness level of Dermatophytosis Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Dermatophytosis Therapeutics industry, describes the types of Dermatophytosis Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Dermatophytosis Therapeutics market and the development prospects and opportunities of Dermatophytosis Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Dermatophytosis Therapeutics market in Chapter 13.

    By Player:

    • Bayer

    • GSK

    • Abbott

    • Pfizer

    • Astellas Pharma

    • Enzon Pharmaceuticals

    • Merck

    • Sanofi-Aventis

    • Novartis

    By Type:

    • Rx

    • OTC

    By End-User:

    • Hospital

    • Clinic

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Dermatophytosis Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Dermatophytosis Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Dermatophytosis Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Dermatophytosis Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Dermatophytosis Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Dermatophytosis Therapeutics Consumption (2017-2022)

    • 7.2 United States Dermatophytosis Therapeutics Consumption (2017-2022)

    • 7.3 Europe Dermatophytosis Therapeutics Consumption (2017-2022)

    • 7.4 China Dermatophytosis Therapeutics Consumption (2017-2022)

    • 7.5 Japan Dermatophytosis Therapeutics Consumption (2017-2022)

    • 7.6 India Dermatophytosis Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Dermatophytosis Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Dermatophytosis Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Dermatophytosis Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Dermatophytosis Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Dermatophytosis Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Dermatophytosis Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Dermatophytosis Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Dermatophytosis Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Dermatophytosis Therapeutics Consumption Forecast (2022-2028)

    9 Global Dermatophytosis Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Dermatophytosis Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Rx Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global OTC Consumption and Growth Rate (2017-2022)

    • 9.2 Global Dermatophytosis Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Dermatophytosis Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Dermatophytosis Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Rx Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global OTC Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Dermatophytosis Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Dermatophytosis Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Dermatophytosis Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Dermatophytosis Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Dermatophytosis Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Dermatophytosis Therapeutics Market Competitive Analysis

    • 14.1 Bayer

      • 14.1.1 Bayer Company Details

      • 14.1.2 Bayer Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bayer Dermatophytosis Therapeutics Product and Service

    • 14.2 GSK

      • 14.2.1 GSK Company Details

      • 14.2.2 GSK Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 GSK Dermatophytosis Therapeutics Product and Service

    • 14.3 Abbott

      • 14.3.1 Abbott Company Details

      • 14.3.2 Abbott Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Abbott Dermatophytosis Therapeutics Product and Service

    • 14.4 Pfizer

      • 14.4.1 Pfizer Company Details

      • 14.4.2 Pfizer Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Pfizer Dermatophytosis Therapeutics Product and Service

    • 14.5 Astellas Pharma

      • 14.5.1 Astellas Pharma Company Details

      • 14.5.2 Astellas Pharma Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Astellas Pharma Dermatophytosis Therapeutics Product and Service

    • 14.6 Enzon Pharmaceuticals

      • 14.6.1 Enzon Pharmaceuticals Company Details

      • 14.6.2 Enzon Pharmaceuticals Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Enzon Pharmaceuticals Dermatophytosis Therapeutics Product and Service

    • 14.7 Merck

      • 14.7.1 Merck Company Details

      • 14.7.2 Merck Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Merck Dermatophytosis Therapeutics Product and Service

    • 14.8 Sanofi-Aventis

      • 14.8.1 Sanofi-Aventis Company Details

      • 14.8.2 Sanofi-Aventis Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Sanofi-Aventis Dermatophytosis Therapeutics Product and Service

    • 14.9 Novartis

      • 14.9.1 Novartis Company Details

      • 14.9.2 Novartis Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Novartis Dermatophytosis Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Dermatophytosis Therapeutics

    • Figure Dermatophytosis Therapeutics Picture

    • Table Global Dermatophytosis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Dermatophytosis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Dermatophytosis Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Dermatophytosis Therapeutics Consumption by Country (2017-2022)

    • Figure United States Dermatophytosis Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Dermatophytosis Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Dermatophytosis Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Dermatophytosis Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Dermatophytosis Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Dermatophytosis Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Dermatophytosis Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Dermatophytosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Dermatophytosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Dermatophytosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Dermatophytosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Dermatophytosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Dermatophytosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rx Consumption and Growth Rate (2017-2022)

    • Figure Global OTC Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Rx Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global OTC Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Dermatophytosis Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Dermatophytosis Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Dermatophytosis Therapeutics Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Dermatophytosis Therapeutics Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Dermatophytosis Therapeutics Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Dermatophytosis Therapeutics Product and Service

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Dermatophytosis Therapeutics Product and Service

    • Table Enzon Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Enzon Pharmaceuticals Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Enzon Pharmaceuticals Dermatophytosis Therapeutics Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Dermatophytosis Therapeutics Product and Service

    • Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)

    • Table Sanofi-Aventis Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi-Aventis Dermatophytosis Therapeutics Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Dermatophytosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Dermatophytosis Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.